文献速递胸部CT

基于CT的放射组学在肺结节患者中鉴别惰性与浸润性肺腺癌的预测价值

The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules.
PubMed 文献 · Eur Radiol · 2018-06-04

本回顾性研究纳入402例病理确诊为肺腺癌且表现为小于3cm肺结节的患者,利用60个CT放射组学特征构建基于5个特征的放射组学标签,在训练组和验证组中鉴别原位腺癌/微浸润腺癌与浸润性腺癌的AUC分别为0.95和0.89,该标签与性别为惰性肺腺癌的独立预测因子。

要点

  • 基于5个CT放射组学特征的标签在训练组鉴别AIS/MIA与IA的AUC为0.95,验证组为0.89。
  • 多因素分析显示放射组学标签(OR 13.3)和性别(OR 3.5)是惰性肺腺癌的独立预测因子。
  • 该标签可能有助于指导肺结节患者的干预选择。

核心结论

  • 基于放射组学特征的标签有助于鉴别惰性与浸润性肺腺癌,可能对指导肺结节患者的干预选择有用。

研究设计与样本

  • 回顾性研究,纳入病理确诊的肺腺癌且表现为小于3cm肺结节的患者402例,分为训练组207例和验证组195例,使用内置软件通过手动分割定量提取60个CT放射组学特征,采用LASSO逻辑回归筛选特征并构建放射组学标签,通过ROC曲线和校准曲线评估预测性能并在独立队列中验证。

诊断标准与关键数值

  • 放射组学标签基于5个放射组学特征,在训练组鉴别MIA/AIS与IA的AUC为0.95(95% CI 0.91-0.98),在验证组为0.89(95% CI 0.84-0.93);多因素逻辑分析显示放射组学标签(OR 13.3,95% CI 6.2-28.5,p < 0.001)和性别(OR 3.5,95% CI 1.2-10.9,p = 0.03)是惰性肺腺癌的独立预测因子。

临床应用与阅片要点

  • 作者认为基于放射组学特征的标签有助于鉴别惰性与浸润性肺腺癌,可能对指导肺结节患者的干预选择有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) are assumed to be indolent lung adenocarcinoma with excellent prognosis. We aim to identify these lesions from invasive adenocarcinoma (IA) by a radiomics approach.

METHODS: This retrospective study was approved by institutional review board with a waiver of informed consent. Pathologically confirmed lung adenocarcinomas manifested as lung nodules less than 3 cm were retrospectively identified. In-house software was used to quantitatively extract 60 CT-based radiomics features quantifying nodule's volume, intensity and texture property through manual segmentation. In order to differentiate AIS/MIA from IA, least absolute shrinkage and selection operator (LASSO) logistic regression was used for feature selection and developing radiomics signatures. The predictive performance of the signature was evaluated via receiver operating curve (ROC) and calibration curve, and validated using an independent cohort.

RESULTS: 402 eligible patients were included and divided into the primary cohort (n = 207) and the validation cohort (n = 195). Using the primary cohort, we developed a radiomics signature based on five radiomics features. The signature showed good discrimination between MIA/AIS and IA in both the primary and validation cohort, with AUCs of 0.95 (95% CI, 0.91-0.98) and 0.89 (95% CI, 0.84-0.93), respectively. Multivariate logistic analysis revealed that the signature (OR, 13.3; 95% CI, 6.2-28.5; p < 0.001) and gender (OR, 3.5; 95% CI, 1.2-10.9; p = 0.03) were independent predictors of indolent lung adenocarcinoma.

CONCLUSION: The signature based on radiomics features helps to differentiate indolent from invasive lung adenocarcinoma, which might be useful in guiding the intervention choice for patients with pulmonary nodules.

KEY POINTS: • Based on radiomics features, a signature is established to differentiate adenocarcinoma in situ and minimally invasive adenocarcinoma from invasive lung adenocarcinoma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. She Y, Zhang L, Zhu H, et al. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules. Eur Radiol. 2018. PMID: 29869172. doi:10.1007/s00330-018-5509-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。